Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Inoperable œsophageal Cancer × Chemoradiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 13 Esophageal Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Carcinoma, Non-Small-Cell Lung 8 Uterine Cervical Neoplasms 7 Pancreatic Neoplasms 6 Oropharyngeal Neoplasms 6 Nasopharyngeal Carcinoma 6 Head and Neck Neoplasms 6 Carcinoma, Squamous Cell 5 Esophageal Squamous Cell Carcinoma 3 Carcinoma 3 Thymoma 2 Stomach Neoplasms 2 Neoplasms by Site 2 Neoplasms 2 NSCLC 2 Lymphoma 2 Hypopharyngeal Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Thrombocytopenia 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1 Sinonasal Squamous Cell Carcinoma 1 SCLC, Extensive Stage 1 Resectable Esophageal Cancer 1 Rectal Malignant Neoplasms 1

Interventions

Nivolumab 1 Ipilimumab 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡